|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61N 1/05 | (2006.01) |
| A61B 18/1477 | (2013.01) | ||
| A61N 1/04 | (2006.01) | ||
| A61N 1/327 | (2013.01) | ||
| A61B 18/14 | (2006.01) | ||
| A61B2018/00577 | (2013.01) |
| (11) | Number of the document | 3077041 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14868104.2 |
| Date of filing the European patent application | 2014-12-05 | |
| (97) | Date of publication of the European application | 2016-10-12 |
| (45) | Date of publication and mention of the grant of the patent | 2024-07-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/068774 |
| Date | 2014-12-05 |
| (87) | Number | WO 2015/085162 |
| Date | 2015-06-11 |
| (30) | Number | Date | Country code |
| 201361912172 P | 2013-12-05 | US | |
| 201414451333 | 2014-08-04 | US |
| (72) |
ONIK, Gary, M. , US
MIESSAU, James, A. , US
|
| (73) |
Rfemb Holdings LLC ,
P.O. Box 66, North Branford, CT 06471,
US
|
| (54) | CANCER IMMUNOTHERAPY BY RADIOFREQUENCY ELECTRICAL MEMBRANE BREAKDOWN (RF-EMB) |
| CANCER IMMUNOTHERAPY BY RADIOFREQUENCY ELECTRICAL MEMBRANE BREAKDOWN (RF-EMB) |